GeneXP Biosciences Inc.
This article was originally published in Start Up
Executive Summary
The managers of GeneXP Biosciences think the global views of gene expression afforded by Affymetrix's microarray chips have their limitations--too much information. GeneXP aims to serve researchers who are ready to focus on specific gene sets. It will sell companies the tools and equipment they need to do high-throughput gene expression studies--or do the work for them.
You may also be interested in...
Microarrays Aim for Center Stage
Accepted in discovery, microarrays are paving the way for biomarker development and eventually, molecular diagnostics.
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.